Search
Searching Content indexed under Food and Drugs Law by Natasha Pearman ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
The Potential Implications Of A Brexit Customs Union On Pharma And Biotech Industries
This would represent a ‘soft Brexit', and would also mean the UK would not be free to strike its own trade deals with non-EU countries.
UK
2 Mar 2018
2
Infliximab: Battle Of The Biosimilars
On 23 May, the CMA issued a statement of objections, which is a provisional finding that Merck Sharp & Dohme Limited (MSD) has breached UK competition law by abusing its dominant position.
UK
27 Nov 2017
Links to Result pages
 
1